Promega Corporation
Home » Products + Services » Drug Discovery »

Custom Assay Materials

CAS_advert_280x90

Related Articles

Related Resources

Need Assistance? Chat

Protease Assays 4620CA
Stay A Step Ahead

Use the latest materials developed by Promega Custom Assay Services to advance your discovery programs and keep ahead of the pack. Choose from a range of vectors and cell lines based on proven, versatile luciferase reporter systems and HaloTag® labeling technologies.

Looking for something not listed here? Let's Build It Together

Featured

Luciferase Pathway Reporters

Cell lines and vectors for pathway analysis, including cytokine modulators and toxicity pathway studies such as heat shock, hypoxia and DNA damage.

GPCR Analysis Featuring GloSensor™ Assay

Cell lines and vectors incorporating Promega’s GloSensor™ live-cell bioluminescent detection technology. Use for kinetic studies of signal transduction through cAMP or cGMP as well as for proteases.

Mammalian Expression Vectors for HaloTag® Protein Analysis

A wide variety of Flexi Vectors and multiple cloning site vectors that allow live cell imaging, protein localization & trafficking, cell-to-gel analysis, and protein pulldowns.

Featured Resources

ProductResources_fr Drug Discovery

Promega offers homogeneous ultrahigh-throughput assays for compound profiling, biologics screening, detecting mechanism of cell death, determining cell health and measuring metabolic responses such as CYP450 activity.

citations_fr A brighter, more sensitive luciferase assay: Learn more about NanoLuc™ luciferase technology in this ACS Chem. Biol. paper

Promega

Sobre Nosotros

Connect With Us

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.